Kangli Guo

607 total citations · 1 hit paper
13 papers, 472 citations indexed

About

Kangli Guo is a scholar working on Biomedical Engineering, Materials Chemistry and Molecular Biology. According to data from OpenAlex, Kangli Guo has authored 13 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Biomedical Engineering, 6 papers in Materials Chemistry and 4 papers in Molecular Biology. Recurrent topics in Kangli Guo's work include Nanoplatforms for cancer theranostics (8 papers), Immune cells in cancer (3 papers) and Advanced Nanomaterials in Catalysis (3 papers). Kangli Guo is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), Immune cells in cancer (3 papers) and Advanced Nanomaterials in Catalysis (3 papers). Kangli Guo collaborates with scholars based in China and Macao. Kangli Guo's co-authors include Nana Zhao, Fu‐Jian Xu, Xiaoyi Zhao, Kai Zhang, Zhiwen Liu, Xiaokang Ding, Ying Wang, Xu Chen, Meiwan Chen and Shun Duan and has published in prestigious journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Kangli Guo

12 papers receiving 467 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Janus nanoparticles targeting extracellular polymeric substance achieve flexible elimination of drug-resistant biofilms

2023 110 citations Zhiwen Liu, Kangli Guo et al. Nature Communications profile →

Peers

Kangli Guo

BE

MB

MC

BIOMA

IMMUN

Manse Kim South Korea

Zhiyong Qian China

Edyta Swider Netherlands

Shang Qiu China

Duotian Qin United States

Liucan Wang China

Pei-Ru Jheng Taiwan

Shameer Pillarisetti South Korea

Hongtong Lu China

K. Vijaya Krishna India

Manse Kim South Korea

Kangli Guo

276 ×0.9

BE

133 ×1.0

MB

128 ×1.0

MC

163 ×1.3

BIOMA

70 ×1.1

IMMUN

Citations per year, relative to Kangli Guo Kangli Guo (= 1×) peers Manse Kim

Countries citing papers authored by Kangli Guo

Since Specialization

Citations

This map shows the geographic impact of Kangli Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kangli Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kangli Guo more than expected).

Fields of papers citing papers by Kangli Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kangli Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kangli Guo. The network helps show where Kangli Guo may publish in the future.

Co-authorship network of co-authors of Kangli Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Kangli Guo. A scholar is included among the top collaborators of Kangli Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kangli Guo. Kangli Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Guo, Kangli, et al.. (2025). Au@Pt Nanoparticles Enhance Maturation and Contraction of Mouse Embryonic Stem Cells-Derived and Neonatal Mouse Cardiomyocytes. Tissue Engineering and Regenerative Medicine. 22(5). 611–625.

2.

Zhao, Xiaoyi, Ying Wang, Xiaoguang Dai, et al.. (2024). Facile construction of polycation/Au@CuS nanohybrids for synergistic gene/photothermal therapy. Chemical Engineering Journal. 486. 150271–150271. 16 indexed citations

3.

Chen, Linghui, Beibei Chen, Kangli Guo, et al.. (2024). Immunomodulatory hydrogel neutralizes tumor acidity to augment immune responses for the prevention of post-surgical recurrence of melanoma. Science China Materials. 68(1). 270–279. 4 indexed citations

4.

Dai, Xiaoguang, Zhiwen Liu, Xiaoyi Zhao, et al.. (2024). NIR‐II‐Responsive Hybrid System Achieves Cascade‐Augmented Antitumor Immunity via Genetic Engineering of Both Bacteria and Tumor Cells. Advanced Materials. 36(40). e2407927–e2407927. 10 indexed citations

5.

Zhao, Xiaoyi, Kangli Guo, Kai Zhang, et al.. (2024). Degradable CRISPR/Cas9 nanosystem activated by NIR-II light targets genome editing of PD-L1 and metabolic modulation for enhanced antitumor immunity. Nano Today. 55. 102186–102186. 9 indexed citations

6.

Zhao, Nana, Qi Yin, Xiaoyi Zhao, et al.. (2023). Injectable Hydrogels Encapsulating Dual-Functional Au@Pt Core–Shell Nanoparticles Regulate Infarcted Microenvironments and Enhance the Therapeutic Efficacy of Stem Cells through Antioxidant and Electrical Integration. ACS Nano. 17(3). 2053–2066. 76 indexed citations

7.

Liu, Zhiwen, Kangli Guo, Kai Zhang, et al.. (2023). Janus nanoparticles targeting extracellular polymeric substance achieve flexible elimination of drug-resistant biofilms. Nature Communications. 14(1). 110 indexed citations breakdown →

8.

Chen, Beibei, Kangli Guo, Xiaoyi Zhao, et al.. (2023). Tumor microenvironment‐responsive delivery nanosystems reverse immunosuppression for enhanced CO gas/immunotherapy. SHILAP Revista de lepidopterología. 3(6). 20220140–20220140. 80 indexed citations

9.

Guo, Kangli, et al.. (2023). Melanin-Based Immunoregulatory Nanohybrids Enhance Antitumor Immune Responses in Breast Cancer Mouse Model. ACS Nano. 17(11). 10792–10805. 35 indexed citations

10.

Chen, Beibei, et al.. (2023). NIR-II responsive Janus nanoparticles amplify immunogenic cell death for enhanced cancer immunotherapy. Science China Technological Sciences. 67(1). 321–329. 2 indexed citations

11.

Zhao, Xiaoyi, Kangli Guo, Kai Zhang, et al.. (2022). Orchestrated Yolk–Shell Nanohybrids Regulate Macrophage Polarization and Dendritic Cell Maturation for Oncotherapy with Augmented Antitumor Immunity. Advanced Materials. 34(9). e2108263–e2108263. 92 indexed citations

12.

Liu, Zhiwen, Kangli Guo, Nana Zhao, & Fu‐Jian Xu. (2019). Polysaccharides-based nanohybrids: Promising candidates for biomedical materials. Science China Materials. 62(12). 1831–1836. 13 indexed citations

13.

Guo, Kangli, Xiaoyi Zhao, Xiaoguang Dai, Nana Zhao, & Fu‐Jian Xu. (2019). Organic/inorganic nanohybrids as multifunctional gene delivery systems. The Journal of Gene Medicine. 21(5). e3084–e3084. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact